The Bigger Concern: Leaving a Deficiency Untreated When weighing the minimal risks of B12 injections, it helps to consider the well-documented risks of an untreated B12 deficiency
AOD9604, on the other hand, hasnt demonstrated the same level of statistically significant outcomes in humans (trial overview)
Risks include mild gastrointestinal discomfort, headaches, injection site irritation, and unknown long-term effects
BPC-157 (5mg Vial) Dosage Protocol BPC-157 is a synthetic pentadecapeptide derived from a protein in gastric juice, studied preclinically for tissue repair, recovery from soft-tissue injury, and protection of the gastrointestinal lining
This doesn't mean they're dangerous or ineffective, but it does mean: Limited clinical data: Without the trials required for approval, human data remains sparse